AngioDynamics Q4 Loss Narrows; Issues Q1, FY14 Outlook - Quick Facts

(RTTNews) - Medical devices maker AngioDynamics Inc. (ANGO), Thursday reported fourth-quarter net loss of about $0.9 million or $0.02 per share, narrower than $7.0 million or $0.27 per share last year.

Adjusted net income for the quarter rose to $2.3 million or $0.07 per share from $0.8 million or $0.03 per share in the year-ago period.

On average, five analysts polled by Thomson Reuters expected the company to report earnings of $0.06 per share. Analysts' estimates typically exclude special items.

Net sales for the latest fourth quarter grew to $90.03 million from $57.69 million last year, while four analysts estimated sales of $86.43 million for the quarter.

Looking forward to the first quarter, the company expects adjusted earnings to be in the range of $0.02 to $0.04 per share and revenues to range from $81 million to $84 million.

Analysts now expect first quarter earnings of $0.08 per share on revenues of $84.74 million.

For full year 2014, the company expects adjusted earnings of $0.31 to $0.35 per share and revenues of $346 million to $352 million.

Analysts currently estimate earnings of $0.33 per share on revenues of $350.33 million for full year 2014.